サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1008063

体外受精(IVF)市場：2020～2026年

In-Vitro Fertilization (IVF) Market 2020-2026
出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.89円
体外受精(IVF)市場：2020～2026年
出版日: 2021年04月07日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の体外受精(IVF)の市場規模は、予測期間中に約9.6%の高いCAGRで拡大すると予測されています。IVFは、不妊症の治療のためのヘルスケア部門で重要な役割を果たしています。これは、子供の受胎をサポートしながら、遺伝的問題を予防し、不妊症を治療するために使用される一連の手技です。体外受精では、女性の卵子と男性の精子をシャーレの中で混ぜ合わせ、子宮に移植します。体外受精には、投薬、採卵、受精、胚培養、胚移植など5つの手順があります。

体外受精の完全なサイクルには、約3週間かかります。これは、40歳以上の不妊の問題を抱える女性に推奨される主要な治療法です。IVFは、授精と細胞質内精子注入法(ICSI)の2つの受精技術によって行うことができます。この治療に使用される装置は、特殊な顕微鏡、インキュベーター、超音波装置、IVFディスポーザブルなどです。排卵障害、原因不明の不妊症、子宮内膜症、子宮筋腫などの問題を抱えている人やそのパートナーに行うことができます。

不妊症の有病率の上昇は、体外受精手順の需要の増加につながり、それによって市場の成長を牽引しています。さらに、生殖補助医療の増加動向と不妊治療へのアクセスを向上させるための政府の有利な取り組みは、市場の成長をさらに推進しています。ただし、治療に伴う高額な費用や、多胎出産、流産、採卵手順の合併症、早産、低体重、子宮外妊娠などのIVF治療に関連するリスクなど、市場の成長を抑制している要因がいくつかあります。ただし、不妊クリニックの拡大は、市場成長の機会を提供しています。

当レポートでは、体外受精(IVF)市場について調査し、市場の概要とともに、手技タイプ別、製品別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
  • ルールと規則

第3章 競合情勢

  • 企業シェア分析
  • 主要な戦略分析
  • 主要企業分析
    • Cooper Surgical, Inc.
    • Vitrolife AB
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Fujifilm Holdings Corp.(Irvine Scientific)

第4章 市場決定要因

  • モチベーター
  • 抑制要因
  • 市場機会

第5章 市場セグメンテーション

  • 世界の体外受精市場、手技タイプ別
    • 凍結ドナー
    • 凍結ノンドナー
    • 新鮮ュドナー
    • 新鮮ノンドナー
  • 世界の体外受精市場、製品別
    • 試薬
    • 装置
    • ソフトウェア
  • 世界の体外受精市場、エンドユーザー別
    • 病院や調査
    • 不妊治療クリニックと外科センター
    • その他

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Cook Medical Inc.
  • CRITEX GmbH
  • Esco Micro Pte Ltd.
  • Genea Ltd.
  • Hamilton Thorne, Inc.
  • Illumina, Inc
  • Inventia Genetic Technologies Pty Ltd.
  • INVO Bioscience Inc.
  • IVFtechApS
  • Kitazato Corp.
  • Nidacon International AB
  • Nikon Corp.
  • Pantec BioSolutions AG
  • Rocket Medical plc
  • Trivector Biomed LLP
図表

LIST OF TABLES

  • 1. GLOBAL IVF MARKETRESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027($ MILLION)
  • 2. GLOBAL FROZEN DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 3. GLOBAL FROZEN NON-DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 4. GLOBAL FRESH DONOR MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 5. GLOBAL FRESH NON-DONOR MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 6. GLOBAL IVFMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027($ MILLION)
  • 7. GLOBAL IVF REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 8. GLOBAL IVF EQUIPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 9. GLOBAL IVF SOFTWAREMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 10. GLOBAL IVF MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)
  • 11. GLOBAL IVF IN HOSPITALS AND LABIRATORIESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL IVF IN FERTILITY CLINICS AND SURGICAL CENTERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL IVF IN OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL IVF MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSISBY COUNTRY, 2020-2027($ MILLION)
  • 16. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027($ MILLION)
  • 17. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027($ MILLION)
  • 18. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSIS BY END-USER,2020-2027($ MILLION)
  • 19. EUROPEAN IVF MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. EUROPEANIVF MARKET RESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027 ($ MILLION)
  • 21. EUROPEANIVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 22. EUROPEANIVF MARKET RESEARCH AND ANALYSIS BY END-USER,2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC IVFMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 24. ASIA-PACIFIC IVFMARKET RESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027($ MILLION)
  • 25. ASIA-PACIFIC IVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027($ MILLION)
  • 26. ASIA-PACIFIC IVF MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 27. REST OF THE WORLD IVFMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 28. REST OF THE WORLD IVFMARKET RESEARCH AND ANALYSIS BY PROCEDURETYPE, 2020-2027($ MILLION)
  • 29. REST OF THE WORLD IVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 30. REST OF THE WORLD IVF MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL IVF MARKET SHARE BY PROCEDURE TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL IVF MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 3. GLOBAL IVF MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 4. GLOBAL IVF MARKETSHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. GLOBAL FROZEN DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 6. GLOBAL FROZEN NON-DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL FRESH DONOR IVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL FRESH NON-DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL IVF REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL IVF EQUIPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL IVF SOFTWAREMARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL IVF IN HOSPITALS AND RESEARCH LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL IVF IN FERTILITY CLINICSAND SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL IVF IN OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 15. US IVFMARKET SIZE, 2020-2027($ MILLION)
  • 16. CANADA IVF MARKETSIZE, 2020-2027($ MILLION)
  • 17. UK IVFMARKET SIZE, 2020-2027($ MILLION)
  • 18. FRANCE IVF MARKET SIZE, 2020-2027($ MILLION)
  • 19. GERMANY IVF MARKET SIZE, 2020-2027($ MILLION)
  • 20. ITALY IVF MARKET SIZE, 2020-2027($ MILLION)
  • 21. SPAIN IVF MARKET SIZE, 2020-2027($ MILLION)
  • 22. REST OF EUROPE IVF MARKETSIZE, 2020-2027($ MILLION)
  • 23. INDIA IVF MARKET SIZE, 2020-2027($ MILLION)
  • 24. CHINA IVFMARKETSIZE, 2020-2027($ MILLION)
  • 25. JAPAN IVF MARKET SIZE, 2020-2027($ MILLION)
  • 26. REST OF ASIA-PACIFIC IVF MARKET SIZE, 2020-2027($ MILLION)
  • 27. REST OF THE WORLD IVF MARKET SIZE, 2020-2027($ MILLION)
目次
Product Code: OMR2023356

Global In-Vitro Fertilization (IVF) Market By Procedure Type (Frozen Donor, Frozen Non-Donor, Fresh Donor, Fresh Non-Donor, Embryo Banking), By Product (Reagents, Equipment, and Software), By End-User (Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, and Others), Forecast Period 2021-2027

The global in-vitro fertilization (IVF) market is growing at a significant CAGR of nearly 9.6% during the forecast period. IVF plays a vital role in the health care sector for the treatment of infertility. It is a series of procedures that are used to prevent genetic problems and treat infertility while supporting the conception of a child. Under the IVF procedure, a woman's egg and a man's sperm are combined in a laboratory dish and then it is transferred to a uterus. There is five procedure involved in the IVF procedure such as medication, harvest the eggs, fertilization, embryo culture, and embryo transfer.

A full cycle of IVF can take about three weeks. It is a primary treatment that is suggested for women with infertility problem above the age of 40. IVF can be done by two fertilization techniques that are insemination and intracytoplasmic sperm injection (ICSI). The devices that are used for this treatment are the special microscope, incubators, ultrasound machines, IVF disposables and other such devices. It can be done if people and their partner have problems such as ovulation disorders, unexplained infertility, endometriosis, uterine fibroids, among other problems.

An increasing prevalence of infertility is leading to increasing demand for IVF procedure and thereby is driving the market growth. Additionally, the increasing trends of assisted reproductive technology and favorable government initiatives to increase the accessibility of infertility treatment are further driving the growth of the market. However, some factors are restraining the market growth include high cost associated with the treatment, and the risk associated with the IVF treatment such as multiple births, miscarriage, egg-retrieval procedure complications, premature delivery and low birth weight, and ectopic pregnancy, among others. However, the expansion of infertility clinics is offering an opportunity for market growth.

Segmental Outlook

The market is segmented based on procedure type, product, and end-user. Based on procedure type, the market is segmented into the frozen donor, frozen non-donor, fresh donor, and fresh non-donor. Based on the product, the market is segmented into reagents, equipment, and software. Based on the end-user, the market is segmented into hospitals and research laboratories, fertility clinics and surgical centers, and others.

Global IVF Market Share by End User, 2020 (%)

Source: OMR Global

Fertility Clinics and Surgical Centers to Witness Fastest Growth During the Forecast Period

Expansion of fertility clinics is one of the major factors resulting in a potential share of fertility clinics and surgical centers. Rising incidences of infertility have resulted in the expansion of fertility clinics and surgical centers. For instance, in November 2020, Nova IVF Fertility launched a new state-of-the-art IVF center in Kolkata, India. The center is led by highly qualified IVF specialists, trained embryologists, Global Standards and Protocols, the latest embryology lab, and a comprehensive range of fertility solutions. Other major fertility clinics focusing on the expansion of their centers globally include IntegraMed America, Inc. and Western Fertility Institute.

Regional Outlook

The market is analyzed based on geographical regions such as North America, Europe, Asia Pacific, and the Rest of the World. Europe is one of the major markets for IVF treatment globally. Rising incidences of infertility and rising medical tourism are some factors accelerating the demand for IVF treatment across Europe. As per the Fertility Europe VZW data published in October 2020, over 25 million citizens are affected by infertility across Europe. Additionally, significant focus on advanced technologies and the availability of IVF treatment at low cost are some of the major causes that are surging the market growth in Europe.

Global IVF Market Growth by Region, 2021-2027

Source: OMR Global

Asia-Pacific is Expected to Witness Potential Share in the Market During the Forecast Period

Asia-Pacific is estimated to be the fastest-growing market during the forecast period. Several factors are driving the growth of the market such as increasing ovulation disorder in women, increasing trends of assisted reproduction technology, and increasing rate of infertility. Additionally, government initiatives for fertility treatment are expected to offer an opportunity for market growth. For instance, in November 2017, the Telangana government (Indian state) declared that it will start fertility centers at government hospitals to increase the accessibility of infertility treatment among couples. This, in turn, is expected to further drive the market growth in the region.

Market Players Outlook

Key players operating in the market include CooperSurgical, Inc., Vitrolife AB, Thermo Fisher Scientific Inc., Merck KGaA, and Fujifilm Holdings Corp. To survive in the market, these market players adopt different marketing strategies such as merger and acquisitions, product launches, and geographical expansion to expand their market share. For instance, in February 2021, TMRW Life Sciences declared that it has launched the world's first automated cryo specimen management solution for embryos and eggs used in IVF. TMRW's proprietary platform has been installed in multiple premier fertility clinics in the US, launching the modern era of integrated, software-enabled management of the millions of eggs and embryos central to modern IVF. The company is expanding globally and declared that it will be in UK-based fertility clinics in the summer of 2021.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global IVF market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules and Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Cooper Surgical, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Vitrolife AB
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Thermo Fisher Scientific Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Merck KGaA
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Fujifilm Holdings Corp. (Irvine Scientific)
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global IVF Market by Procedure Type
    • 5.1.1. Frozen Donor
    • 5.1.2. Frozen Non-Donor
    • 5.1.3. Fresh Donor
    • 5.1.4. Fresh Non-Donor
  • 5.2. Global IVF Market by Product
    • 5.2.1. Reagents
    • 5.2.2. Equipment
    • 5.2.3. Software
  • 5.3. Global IVF Market by End-User
    • 5.3.1. Hospitals and Research Laboratories
    • 5.3.2. Fertility Clinicsand Surgical Centers
    • 5.3.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Cook Medical Inc.
  • 7.2. CRITEX GmbH
  • 7.3. Esco Micro Pte Ltd.
  • 7.4. Genea Ltd.
  • 7.5. Hamilton Thorne, Inc.
  • 7.6. Illumina, Inc
  • 7.7. Inventia Genetic Technologies Pty Ltd.
  • 7.8. INVO Bioscience Inc.
  • 7.9. IVFtechApS
  • 7.10. Kitazato Corp.
  • 7.11. Nidacon International AB
  • 7.12. Nikon Corp.
  • 7.13. Pantec BioSolutions AG
  • 7.14. Rocket Medical plc
  • 7.15. Trivector Biomed LLP